Expanded Preclinical Solutions

Transposagen has merged its research technologies and services business with Hera BioLabs. With our combined unique capabilities in gene editing reagents, cell line engineering and in vivo oncology services we provide solutions for your preclinical development milestones.

• Hera BioLabs
• Gene Editing Reagents
• Cell Line Engineering
• Preclinical Oncology Services